Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,313 | 1,072 | 90.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,576 | 5 | 6.7% |
| Travel and Lodging | $398.59 | 2 | 1.7% |
| Education | $235.51 | 6 | 1.0% |
| Consulting Fee | $150.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $2,691 | 41 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $2,398 | 238 | $0 (2024) |
| ABBVIE INC. | $1,787 | 113 | $0 (2024) |
| Amgen Inc. | $1,624 | 67 | $0 (2024) |
| UCB, Inc. | $1,465 | 41 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $1,185 | 42 | $0 (2024) |
| SK Life Science, Inc. | $1,157 | 39 | $0 (2024) |
| ARGENX US, INC. | $1,119 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $878.43 | 45 | $0 (2024) |
| GENZYME CORPORATION | $813.17 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,551 | 151 | ABBVIE INC. ($731.90) |
| 2023 | $3,426 | 137 | ARGENX US, INC. ($558.77) |
| 2022 | $2,976 | 146 | Teva Pharmaceuticals USA, Inc. ($310.33) |
| 2021 | $2,957 | 165 | Greenwich Biosciences, Inc. ($314.48) |
| 2020 | $1,588 | 104 | Allergan, Inc. ($355.32) |
| 2019 | $2,174 | 104 | Teva Pharmaceuticals USA, Inc. ($427.77) |
| 2018 | $1,996 | 130 | Teva Pharmaceuticals USA, Inc. ($260.36) |
| 2017 | $5,005 | 149 | Supernus Pharmaceuticals, Inc. ($2,406) |
All Payment Transactions
1,086 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.30 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: Central Nervous System | ||||||
| 11/26/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $36.56 | General |
| Category: Neurology | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: PAIN | ||||||
| 11/22/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.34 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Immunology and Neurology | ||||||
| 11/12/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $29.12 | General |
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Neuroscience | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: PAIN | ||||||
| 10/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Rare Disease | ||||||
| 10/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: PAIN | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Central Nervous System | ||||||
| 10/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.43 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $30.49 | General |
| 10/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $34.47 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 741 | 871 | $278,605 | $79,466 |
| 2022 | 9 | 608 | 745 | $189,866 | $62,212 |
| 2021 | 8 | 471 | 584 | $138,832 | $51,455 |
| 2020 | 8 | 524 | 603 | $131,149 | $49,688 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 171 | 249 | $79,680 | $22,195 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 86 | 92 | $41,768 | $12,229 | 29.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 65 | 65 | $36,335 | $10,463 | 28.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 29 | 30 | $28,968 | $8,686 | 30.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 28 | 28 | $23,704 | $7,489 | 31.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 124 | 155 | $23,715 | $6,589 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $16,074 | $4,379 | 27.2% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 49 | 51 | $7,854 | $2,456 | 31.3% |
| 92250 | Photography of the retina | Office | 2023 | 74 | 76 | $9,576 | $2,095 | 21.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 58 | 65 | $5,915 | $1,601 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 22 | $5,016 | $1,284 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 247 | $71,354 | $22,402 | 31.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 76 | 76 | $36,100 | $12,475 | 34.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 69 | 78 | $31,317 | $11,162 | 35.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 106 | 141 | $19,113 | $6,479 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $11,162 | $3,133 | 28.1% |
| 92250 | Photography of the retina | Office | 2022 | 68 | 70 | $6,332 | $2,029 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 31 | $6,213 | $1,905 | 30.7% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2022 | 28 | 32 | $4,868 | $1,507 | 31.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 34 | 41 | $3,407 | $1,120 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 144 | 211 | $54,649 | $19,813 | 36.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 67 | 67 | $29,949 | $10,742 | 35.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 60 | 69 | $25,047 | $9,365 | 37.4% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 91 | 121 | $14,883 | $5,890 | 39.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $4,732 | $1,926 | 40.7% |
About Dr. Bryan Riggeal, M.D
Dr. Bryan Riggeal, M.D is a Ophthalmology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104023308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Riggeal, M.D has received a total of $23,672 in payments from pharmaceutical and medical device companies, with $3,551 received in 2024. These payments were reported across 1,086 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($21,313).
As a Medicare-enrolled provider, Riggeal has provided services to 2,344 Medicare beneficiaries, totaling 2,803 services with total Medicare billing of $242,821. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Neurology
- Location Jacksonville, FL
- Active Since 06/29/2007
- Last Updated 10/25/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1104023308
Products in Payments
- TROKENDI XR (Drug) $2,691
- Aimovig (Biological) $1,587
- UBRELVY (Drug) $1,555
- AJOVY (Biological) $1,323
- Briviact (Drug) $877.95
- VYVGART (Drug) $857.43
- AUBAGIO (Drug) $621.79
- ULTOMIRIS (Biological) $568.41
- Epidiolex (Drug) $566.64
- Fycompa (Drug) $535.90
- XCOPRI (Drug) $512.01
- NURTEC ODT (Drug) $501.57
- EPIDIOLEX (Drug) $486.36
- QULIPTA (Drug) $480.72
- TEPEZZA (Drug) $440.35
- TYSABRI (Biological) $420.04
- AUSTEDO (Drug) $407.62
- VALTOCO (Drug) $359.50
- VYEPTI (Biological) $285.99
- ACTHAR (Biological) $275.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Jacksonville
Syril Dorairaj, Md, MD
Ophthalmology — Payments: $542,154
Jeffrey Levenson, M.d, M.D
Ophthalmology — Payments: $435,025
Dr. Frank Bowden, M.d, M.D
Ophthalmology — Payments: $213,959
David Kostick, Md, MD
Ophthalmology — Payments: $96,443
Benjamin Thomas, Md, MD
Ophthalmology — Payments: $76,189
Ron Adelman, Md, MD
Ophthalmology — Payments: $62,231